Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Macaluso has nothing to disclose.
Conflict of interest: Dr. Alzaher has nothing to disclose.
Conflict of interest: Dr. Chaube has nothing to disclose.
Conflict of interest: Dr. Chua has nothing to disclose.
Conflict of interest: Dr. Wells reports speakers and consultancy fees from Intermune Roche, Boehringer ingelheim and Bayer
Conflict of interest: TMM has, via his institution, received industry-academic funding from GlaxoSmithKline R&D and UCB and has received consultancy or speakers fees from Apellis, Astra Zeneca, aTyr Pharma, Bayer, Biogen Idec, Boehringer Ingelheim, Galapagos, GlaxoSmithKline R&D, ProMetic, Roche, Sanumed and UCB.
Conflict of interest: Dr. George reports personal fees from Roche Pharmaceuticals, personal fees from Boehringer Ingelheim, outside the submitted work.
Conflict of interest: Dr. Renzoni has recieved speakers fees from BI, Roche and Mundipharma
Conflict of interest: Dr. Molyneaux has nothing to disclose.
Conflict of interest: Dr. Maritano Furcada has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©ERS 2018
